|
Adams, I B; Compton, D R; Martin, B R (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284:1209-17
|
|
Compton, D R; Martin, B R (1997) The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J Pharmacol Exp Ther 283:1138-43
|
|
Lake, K D; Martin, B R; Kunos, G et al. (1997) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29:1204-10
|
|
Willoughby, K A; Moore, S F; Martin, B R et al. (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243-7
|
|
Shivachar, A C; Martin, B R; Ellis, E F (1996) Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Biochem Pharmacol 51:669-76
|
|
Ellis, E F; Moore, S F; Willoughby, K A (1995) Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol 269:H1859-64
|
